Nisa Investment Advisors
CKPT

Nisa Investment Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Nisa Investment Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,000
Closed -$127K – 2359
2021
Q4 		$127K Hold
5,000
– – ﹤0.01% 1423
2021
Q3 		$165 Hold
5,000
– – ﹤0.01% 1482
2021
Q2 		$148 Hold
5,000
– – ﹤0.01% 1520
2021
Q1 		$157 Hold
5,000
– – ﹤0.01% 1557
2020
Q4 		$133K Buy
+5,000
New +$127K ﹤0.01% 1621

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nisa Investment Advisors's CKPT Position: Q1 2022 in Review

Nisa Investment Advisors sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 5,000 shares — an estimated $127K sold.

Nisa Investment Advisors first reported a position in CKPT in Q4 2020 and held it in 5 quarters. The position peaked at $133K in Q4 2020. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.

  • Nisa Investment Advisors reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 5,000 Checkpoint Therapeutics shares in Q1 2022, an estimated $127K.
  • Nisa Investment Advisors first reported a position in Checkpoint Therapeutics in Q4 2020 and held it in 5 quarters.
  • Nisa Investment Advisors's Checkpoint Therapeutics position peaked at $133K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.

Based on Nisa Investment Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.